Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolent Health, Inc.EVH · Entity 5492 | Director | June 05, 2025 | June 09, 2025 |
| Progyny, Inc.PGNY · Entity 4521 | Director | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolent Health, Inc.
Report date June 05, 2025 · Filed June 09, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 73,476 |
Reported balance
After 2025-06-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-05 · Grant · Acquired 21,979 · Balance 73,476 F1: Represents restricted stock units granted to Ms. Scott pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Ms. Scott pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.
Progyny, Inc.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,772 |
Ending reported balance
After 2026-06-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-06-01 · Exercise / conversion · Acquired 14,667 · Balance 34,439 Row 2 · 2026-06-01 · Tax withholding · Disposed 7,228 · Balance 27,211 Row 3 · 2026-06-01 · Sale · Disposed 7,439 · Balance 19,772 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.00 · Expires 2029-10-23 | Direct | 29,333 |
Reported balance
After 2026-06-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-01 · Exercise / conversion · Disposed 14,667 · Balance 29,333 F1: One-fourth (1/4th) of the shares subject to the Option shall vest on October 24, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth (1/4th) of the shares subject to the Option shall vest on October 24, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:53 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,667 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001551306-26-000118 · wk-form4_1780519988.xml · derivative · entry 4 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,333 Underlying: Common Stock · 14,667 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option shall vest on October 24, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:53 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,439 | $26.39 | $196,278.02 |
DisclosureSEC source: 0001551306-26-000118 · wk-form4_1780519988.xml · nonDerivative · entry 3 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,772 Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:53 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 7,228 | $26.38 | $190,674.64 |
DisclosureSEC source: 0001551306-26-000118 · wk-form4_1780519988.xml · nonDerivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,211 Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:53 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 14,667 | $13.00 | $190,671.00 |
DisclosureSEC source: 0001551306-26-000118 · wk-form4_1780519988.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 27,119 | $0.00 Strike: $24.69 | $0.00 |
DisclosureSEC source: 0001551306-26-000095 · wk-form4_1779826867.xml · derivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,119 Underlying: Common Stock · 27,119 shares Expires 2036-05-20 F2 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 5,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-26-000095 · wk-form4_1779826867.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,772 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 21:07 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,675 | $22.07 | $59,037.25 |
DisclosureSEC source: 0001551306-25-000146 · wk-form4_1749762427.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,112 Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 11:13 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000088 · wk-form4_1749467620.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,476 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| May 22, 2025 Filed May 28, 2025 12:05 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 30,401 | $0.00 Strike: $20.89 | $0.00 |
DisclosureSEC source: 0001551306-25-000126 · wk-form4_1748433938.xml · derivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,401 Underlying: Common Stock · 30,401 shares Expires 2035-05-21 F2 · derivative.exercise_date: The shares subject to the option will vest on May 22, 2026, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 22, 2025 Filed May 28, 2025 12:05 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 6,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-25-000126 · wk-form4_1748433938.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,787 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on May 22, 2026, subject to the Reporting Person's continued service on such date. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 18:14 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,462 | $28.39 | $41,506.18 |
DisclosureSEC source: 0001551306-24-000140 · wk-form4_1719857672.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,098 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.385 to $28.3947, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:35 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000076 · wk-form4_1718062537.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,497 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| May 23, 2024 Filed May 29, 2024 01:36 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 23,212 | $0.00 Strike: $27.15 | $0.00 |
DisclosureSEC source: 0001551306-24-000112 · wk-form4_1716946583.xml · derivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,212 Underlying: Common Stock · 23,212 shares Expires 2034-05-22 F2 · derivative.exercise_date: The shares subject to the option will vest on May 23, 2025, subject to the Reporting Person's continued service on such date. Read SEC document |
| May 23, 2024 Filed May 29, 2024 01:36 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 5,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-24-000112 · wk-form4_1716946583.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,560 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on May 23, 2025, subject to the Reporting Person's continued service on such date. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 19:56 UTC | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-23-000100 · wk-form4_1700682994.xml · nonDerivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,413 Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 19:56 UTC | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 3,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-23-000100 · wk-form4_1700682994.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,443 Read SEC document |
| June 27, 2023 Filed Jul 7, 2023 21:15 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,170 | $37.27 | $43,605.90 |
DisclosureSEC source: 0001628280-23-024570 · wf-form4_168876450467408.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,744 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:38 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 2,365 | $30.01 | $70,973.65 |
DisclosureSEC source: 0001628908-23-000103 · wf-form4_168694791322139.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,788 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:21 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 5,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-23-000086 · wf-form4_168660488009803.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,153 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 8, 2024 and the date of the Company's 2024 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| May 24, 2023 Filed May 26, 2023 21:07 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 16,990 | $0.00 Strike: $38.24 | $0.00 |
DisclosureSEC source: 0001628280-23-019981 · wf-form4_168513523277188.xml · derivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,990 Underlying: Common Stock · 16,990 shares Expires 2033-05-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| May 24, 2023 Filed May 26, 2023 21:07 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 3,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019981 · wf-form4_168513523277188.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,914 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 850 | $40.78 | $34,663.00 |
DisclosureSEC source: 0001628280-22-029210 · wf-form4_166802775127960.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,260 F1 · kind: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 21:04 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $38.22 | $0.00 |
DisclosureSEC source: 0001628280-22-027089 · wf-form4_166681827335876.xml · derivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2032-10-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 21:04 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-027089 · wf-form4_166681827335876.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,110 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 21:02 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 3,100 | $36.76 | $113,956.00 |
DisclosureSEC source: 0001628908-22-000124 · wf-form4_166206612611091.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.75 to $36.79, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 22:25 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 5,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000081 · wf-form4_165515911579815.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,204 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 9, 2023 and the date of the company's 2023 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,000 | $66.30 | $132,600.00 |
DisclosureSEC source: 0001179110-21-010039 · edgar.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,210 F1 · shares: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 21:53 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 14,658 | $0.00 Strike: $63.21 | $0.00 |
DisclosureSEC source: 0001179110-21-009640 · edgar.xml · derivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,658 Underlying: Common Stock · 14,658 shares Expires 2026-10-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on October 24, 2022, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 21:53 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 2,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-009640 · edgar.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,210 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on October 24, 2022, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 6,405 | $19.39 | $124,192.95 |
DisclosureSEC source: 0001628908-21-000090 · wf-form4_162379131337267.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,640 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.22 to $19.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:35 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 7,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-21-000077 · wf-form4_162370653836039.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,045 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 10, 2022 and the date of the company's 2022 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 03, 2021 Filed Feb 14, 2022 22:24 UTC | Evolent Health, Inc. EVH · Entity 5492 | GiftClass A Common Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000016 · wf-form5_164487746124173.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,640 F1 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 21:56 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $27.95 | $0.00 |
DisclosureSEC source: 0001209191-20-055960 · doc4.xml · derivative · entry 2 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-10-23 F2 · derivative.exercise_date: The shares subject to the Option shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 21:56 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-055960 · doc4.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on October 24, 2021, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:28 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 18,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-20-000075 · wf-form4_159191091885481.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,260 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 9, 2021 and the date of the company's 2021 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 01:47 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054017 · doc4.xml · derivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2029-10-11 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option shall vest on October 24, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 12:24 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 14,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-19-000045 · primary_doc.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,958 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 11, 2020 and the date of the company's 2020 annual meeting, subject to the reporting person's continued service on the vesting date. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:21 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 5,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-18-000049 · primary_doc.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,802 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 13, 2019 and the date of the company's 2019 annual meeting, subject to the reporting person's continued service on the vesting date. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 20:45 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 1,600 | $22.63 | $36,208.00 |
DisclosureSEC source: 0001628908-18-000039 · primary_doc.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,343 F1 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.60-$22.675, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., and security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:08 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 4,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-17-000028 · primary_doc.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,943 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 8, 2018 and the date of the company's 2018 annual meeting, subject to the reporting person's continued service on the vesting date. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 19, 2017 Filed May 23, 2017 21:24 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 5,477 | $23.51 | $128,764.27 |
DisclosureSEC source: 0001656979-17-000001 · primary_doc.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,373 F1 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.